User profiles for R. Altman
Russ B AltmanProfessor Stanford University Verified email at stanford.edu Cited by 65169 |
[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
…, RW Moskowitz, G Nuki, S Abramson, RD Altman… - Osteoarthritis and …, 2008 - Elsevier
PURPOSE: To develop concise, patient-focussed, up to date, evidence-based, expert
consensus recommendations for the management of hip and knee osteoarthritis (OA), which are …
consensus recommendations for the management of hip and knee osteoarthritis (OA), which are …
[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research …
…, G Nuki, RW Moskowitz, S Abramson, RD Altman… - Osteoarthritis and …, 2010 - Elsevier
OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 January …
osteoarthritis (OA) and to examine whether research evidence has changed from 31 January …
[PDF][PDF] American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip …
MC Hochberg, RD Altman, KT April… - Arthritis care & …, 2012 - Wiley Online Library
… Altman has received consultant fees, speaking fees, and/or honoraria (less than $10,000
each) from Ferring, Rotta, Endo, Novartis, Lilly, and Smith & Nephew. Dr. Towheed has …
each) from Ferring, Rotta, Endo, Novartis, Lilly, and Smith & Nephew. Dr. Towheed has …
Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee
R Altman, E Asch, D Bloch, G Bole… - … : Official Journal of …, 1986 - Wiley Online Library
For the purposes of classification, it should be specified whether osteoarthritis (OA) of the
knee is of unknown origin (idiopathic, primary) or is related to a known medical condition or …
knee is of unknown origin (idiopathic, primary) or is related to a known medical condition or …
On the opportunities and risks of foundation models
AI is undergoing a paradigm shift with the rise of models (eg, BERT, DALL-E, GPT-3) that are
trained on broad data at scale and are adaptable to a wide range of downstream tasks. We …
trained on broad data at scale and are adaptable to a wide range of downstream tasks. We …
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip
R Altman, G Alarcon, D Appelrouth… - … : Official Journal of …, 1991 - Wiley Online Library
Clinical criteria for the classification of patients with hip pain associated with osteoarthritis (OA)
were developed through a multicenter study. Data from 201 patients who had …
were developed through a multicenter study. Data from 201 patients who had …
Missing value estimation methods for DNA microarrays
Motivation: Gene expression microarray experiments can generate data sets with multiple
missing expression values. Unfortunately, many algorithms for gene expression analysis …
missing expression values. Unfortunately, many algorithms for gene expression analysis …
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand
R Altman, G Alarcon, D Appelrouth… - … : Official Journal of …, 1990 - Wiley Online Library
Clinical criteria for the classification of symptomatic idiopathic (primary) osteoarthritis (OA) of
the hands were developed from data collected in a multi‐center study. Patients with OA …
the hands were developed from data collected in a multi‐center study. Patients with OA …
2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee
…, C Scanzello, D White, B Wise, RD Altman… - Arthritis & …, 2020 - Wiley Online Library
… Altman has received consulting fees, speaking fees, and/or honoraria from Flexion,
GlaxoSmithKline, Novartis, Olatec, Pfizer, Sorrento Therapeutics, and Teva Pharmaceutical …
GlaxoSmithKline, Novartis, Olatec, Pfizer, Sorrento Therapeutics, and Teva Pharmaceutical …
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.
MC Hochberg, RD Altman, KD Brandt… - Arthritis and …, 1995 - europepmc.org
A comment on this article appears in" Fluoroscopically directed steroid instillation in the
treatment of hip osteoarthritis: safety and efficacy in 510 cases." Arthritis Rheum. 2001 Oct; 44 (10…
treatment of hip osteoarthritis: safety and efficacy in 510 cases." Arthritis Rheum. 2001 Oct; 44 (10…